In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.

Hosts: Daniel Griffin and Vincent Racaniello

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Novavax vaccine phase 3 results (Novavax)
J&J vaccine phase 3 results (J&J)
COVID-19 and transmission in K-12 schools (MMWR)
Lilly mAb therapy (NEJM)
Regeneron mAb prophylaxis (Regeneron)
Colchicine for COVID-19 (Cardiol Today)
Letters read on TWiV 713
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

TWiV 713: COVID-19 clinical update #47 with Dr. Daniel Griffin